开源证券给予利民股份买入评级，Q2业绩超预期，看好公司创新驱动打造新增长曲线

Group 1 - The core viewpoint of the article is that Limin Co., Ltd. (002734.SZ) has been given a "buy" rating by Kaiyuan Securities due to its strong performance and growth potential [2] - The company's Q2 performance saw a significant increase compared to Q1, continuing to exceed expectations [2] - Prices for products such as Daisen Manganese Zinc and Bacillus Thuringiensis increased in Q2 2024, contributing to further growth in the company's performance [2] - The company is actively innovating in new fields such as synthetic biology, which may create new growth opportunities in the future [2]